Roche’s Risdiplam meets primary endpoint in pivotal FIREFISH trial in infants with type 1 spinal muscular atrophy Read more
Exclusive speaker interview from MRC Harwell Institute released 4 weeks ahead of SMi’s 3D Cell Culture Conference Read more
European Commission approves Roche’s Polivy for people with previously treated aggressive lymphoma Read more